Table 3. Association between components of sarcopenic obesity and risk of impairment in different domains of cognitive function.

	Low ALMI (n = 276)		Low HGS (n = 99)		Low GS (n = 189)		High FMI (n = 216)
	OR (95% CI)	p	OR (95% CI)	p	OR (95% CI)	p	OR (95% CI)	p
Global cognitive function	0.92 (0.51–1.63)	.768	1.71 (0.88–3.31)	.113	1.67 (0.91–3.03)	.096	1.48 (0.85–2.58)	.164
Immediate memory	0.87 (0.52–1.45)	.600	1.91 (1.04–3.49)	.035*	2.17 (1.26–3.72)	< .01**	0.92 (0.56–1.50)	.742
Visuospatial/constructive	0.80 (0.45–1.38)	.419	1.72 (0.91–3.23)	.094	1.40 (0.77–2.51)	.261	1.40 (0.82–2.39)	.214
Language	0.66 (0.40–1.09)	.106	0.88 (0.45–1.65)	.687	1.07 (0.61–1.83)	.811	0.79 (0.49–1.28)	.349
Attention	0.60 (0.34–1.04)	.069	1.21 (0.62–2.32)	.576	1.64 (0.91–2.92)	.095	2.06 (1.22–3.51)	< .01**
Delayed memory	0.88 (0.47–1.63)	.675	1.57 (0.81–3.02)	.180	1.65 (0.85–3.19)	.138	1.42 (0.79–2.58)	.240

Model adjusted for age groups, gender, physical activity levels, diabetes, hypertension, cardiovascular disease, high cholesterol, stroke, depression, and years of education.

ALMI, appendicular lean mass index; HGS, handgrip strength; GS, gait speed; FMI, fat mass index; OR, odds ratio; CI, confidence interval.

*p < .05,

** p < .01.